Search Results - "Sheppard, G L"

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes by Brott, T G, Haley, Jr, E C, Levy, D E, Barsan, W, Broderick, J, Sheppard, G L, Spilker, J, Kongable, G L, Massey, S, Reed, R

“…Thrombolytic agents hold theoretical promise as therapy for cerebral infarction. This study was designed to evaluate the safety of tissue plasminogen…”
Get full text

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset by Haley, Jr, E C, Levy, D E, Brott, T G, Sheppard, G L, Wong, M C, Kongable, G L, Torner, J C, Marler, J R

“…Renewed interest in thrombolytic therapy as potential treatment for patients with acute ischemic stroke prompted a dose-escalation safety study of tissue…”
Get full text

Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke by Levy, D E, Brott, T G, Haley, Jr, E C, Marler, J R, Sheppard, G L, Barsan, W, Broderick, J P

“…Several studies are currently evaluating tissue-type plasminogen activator (TPA) as a potential therapy in acute ischemic stroke. The possibility of inducing…”
Get full text

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke by HALEY, E. C, BROTT, T. G, TORNER, J. C, SHEPPARD, G. L, BARSAN, W, BRODERICK, J, MARLER, J. R, KONGABLE, G. L, SPILKER, J, MASSEY, S, HANSEN, C. A

Get full text

Histology and Mucous Histochemistry of the Integument and Body Wall of a Marine Polychaete Worm, Ophryotrocha n. sp. (Annelida : Dorvilleidae) Associated with Steelhead Trout Cage Sites on the South Coast of Newfoundland by Sheppard, G. L., Gidge, Y. S., Gallardi, D., Murray, H. M.

“…Histology and mucous histochemistry of the integument and body wall of a marine polychaete worm, Ophryotrocha n. sp. (Annelida: Dorvilleidae) associated with…”
Get full text

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group by Haley, Jr, E C, Brott, T G, Sheppard, G L, Barsan, W, Broderick, J, Marler, J R, Kongable, G L, Spilker, J, Massey, S, Hansen, C A

“…Early thrombolytic therapy with recombinant tissue-type plasminogen activator is a theoretically attractive approach to the treatment of acute focal cerebral…”
Get full text

X-linked recessive inheritance of a syndrome of mental retardation with hyperuricemia by Shapiro, S L, Sheppard, Jr, G L, Dreifuss, F E, Newcombe, D S

Get more information

The subclavian steal syndrome. A clinical approach by Van Heerden, J A, Sheppard, Jr, G L, Deignan, Jr, J M

Get more information

Mitral-valve prolapse presenting with seizures: case report by Smirniotopoulos, T T, Sheppard, G L

Get more information

Bilateral Knee Dislocations in an Active Duty Service Member: A Case Report by Anies, Ervin P, Sheppard, Sean G, McDonald, Lucas S, Bailey, James R

“…ABSTRACT This case highlights a staged operative approach for a patient who sustained bilateral knee dislocations and subsequent staged operative treatment and…”
Get full text

Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for actue ischemic stroke by LEVY, D. E, BROTT, T. G, HALEY, E. C, MARLER, J. R, SHEPPARD, G. L, BARSAN, W, BRODERICK, J. P

Get full text

Urgent therapy for stroke. II: Pilot study of tissue plasminogen activator administered 91-180 minutes from onset by HALEY, E. C, LEVY, D. E, BROTT, T. G, SHEPPARD, G. L, WONG, M. C. W, KONGABLE, G. L, TORNER, J. C, MARLER, J. R

Get full text

Urgent therapy for stroke. I: Pilot study of tissue plasminogen activator administered within 90 minutes by BROTT, T. G, HALEY, C. JR, MARLER, J. R, LEVY, D. E, BARSAN, W, BRODERICK, J, SHEPPARD, G. L, SPILKER, J, KONGABLE, G. L, MASSEY, S, REED, R

Get full text

Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS)

“…Tirilazad mesylate, a 21-amino-steroid, is a potent membrane lipid peroxidation inhibitor and free radical scavenger that has shown promise in animal models of…”
Get full text

Tuberculous Meningitis After Intrathecally Administered Methylprednisolone Acetate by Roberts, Melville, Sheppard, George L, McCormick, Regina C

“…THE INTRATHECAL USE of methylprednisolone acetate in the treatment of sciatica and arachnitis was introduced in 1961 by Gardner and associates.1 In reporting 3…”
Get full text

X-linked primary hyperuricaemia (hypoxanthine-guanine phosphoribosyltransferase deficiency encephalopathy by Dreifuss, F E, Newcombe, D S, Shapiro, S L, Sheppard, G L

Get more information

Treatment of X-Linked Primary Hyperuricemia With Allopurinol by Newcombe, David S, Shapiro, Samuel L, Sheppard, George L, Dreifuss, Fritz E

“…LESCH AND NYHAN recently described a disorder of uric acid metabolism and central nervous system function in two brothers consisting of hyperuricemia,…”
Get full text

The Cathedral At Guildford: Lay Support by SHEPPARD, W. G. L, POWELL, LAWRENCE

Get full text

Transportation: a geographical analysis by Black, William R, Sheppard, Jr., Gary L.

Get full text